Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2225 to 2274 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1113\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta(14)-sterol reductase (ec 1.3.1.70) (c-14 sterol reductase) (sterol c14-reductase) (delta14-sr) (transmembrane 7 superfamily member 2) (another new gene 1) (putative sterol reductase sr-1). [source:swissprot;acc:o76062]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7995.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8291.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03703\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoglycerate mutase 1 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme b) (pgam-b) (bpg-dependent pgam 1). [source:swissprot;acc:p18669]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5910.54\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6440.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.08968\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1114\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoglycerate mutase 2 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme m) (pgam-m) (bpg-dependent pgam 2) (muscle-specific phosphoglycerate mutase). [source:swissprot;acc:p15259]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of nonsense transcripts 1 (nonsense mrna reducing factor 1) (norf1) (up-frameshift suppressor 1 homolog). [source:swissprot;acc:q92900]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7954.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8248.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03702\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1115\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5-methyltetrahydrofolate--homocysteine methyltransferase (ec 2.1.1.13) (methionine synthase, vitamin-b12 dependent) (ms). [source:swissprot;acc:q99707]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5795.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6314.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08957\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenin 2 (fragment). [source:swissprot;acc:q9h2a3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7074.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7336.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03701\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1116\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynactin complex 50 kda subunit (50 kda dynein-associated polypeptide) (dynamitin) (dctn-50) (dynactin 2). [source:swissprot;acc:q13561]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5322.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5798.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08948\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 2 (neurod2). [source:swissprot;acc:q15784]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7074.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7336.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03701\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1117\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5322.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5798.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08948\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 6 (neurod6) (my051 protein). [source:swissprot;acc:q96nk8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7074.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7336.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03701\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1118\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, heart/skeletal muscle isoform t1 (adp/atp translocase 1) (adenine nucleotide translocator 1) (ant 1). [source:swissprot;acc:p12235]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5322.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5798.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08948\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 1 (neurod1) (neurod). [source:swissprot;acc:q13562]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7074.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7336.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03701\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1119\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, fibroblast isoform (adp/atp translocase 2) (adenine nucleotide translocator 2) (ant 2). [source:swissprot;acc:p05141]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5322.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5798.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08948\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box protein o1a (forkhead in rhabdomyosarcoma). [source:swissprot;acc:q12778]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7732.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8018.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03701\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1120\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock factor binding protein 1. [source:swissprot;acc:o75506]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5915.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6443.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08932\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 4 (neurod4). [source:swissprot;acc:q9hd90]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7074.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7336.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03701\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1121\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vb (myosin 5b) (fragment). [source:swissprot;acc:q9ulv0]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8237.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8542.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.037\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein nop5 (nucleolar protein 5) (nop58) (hspc120). [source:swissprot;acc:q9y2x3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4338.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4725.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08929\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1122\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 6 (26s proteasome regulatory subunit s10) (p42a) (proteasome regulatory particle subunit p44s10). [source:swissprot;acc:q15008]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8139.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8441.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.037\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
isocitrate dehydrogenase [nadp], mitochondrial precursor (ec 1.1.1.42) (oxalosuccinate decarboxylase) (idh) (nadp+-specific icdh) (idp) (icd-m). [source:swissprot;acc:p48735]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7937.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8646.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08928\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1123\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
argininosuccinate lyase (ec 4.3.2.1) (arginosuccinase) (asal). [source:swissprot;acc:p04424]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5857.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6380.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08927\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal 42kda, v1 subunit c isoform 2; v-atpase c2 subunit. [source:refseq;acc:nm\_144583]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7989.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8285.04\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03699\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1124\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hpaii tiny  fragments locus 9c. [source:refseq;acc:nm\_022727]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7702.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7987.68\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 2 (esg2). [source:swissprot;acc:q04725]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6288.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6846.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08885\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1125\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 gamma 2 subunit (gamma2-adaptin) (adaptor protein complex ap-1 gamma-2 subunit) (g2ad). [source:swissprot;acc:o75843]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7688.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7972.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03697\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 1 (esg1). [source:swissprot;acc:q04724]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6287.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6845.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08879\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1126\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin-dependent kinase 2-associated protein 1 (cdk2-associated protein 1) (putative oral cancer suppressor) (deleted in oral cancer- 1) (doc-1). [source:swissprot;acc:o14519]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7077.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7339.16\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03696\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-6 subunit (karyopherin alpha-5 subunit). [source:swissprot;acc:o15131]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5792.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6305.67\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08867\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1127\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to lim domain only 7 (fragment). [source:sptrembl;acc:q8n6m2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7322.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7592.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03696\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
yip1 interacting factor homolog; yip1p-interacting factor; putative rab5-interacting protein; putative transmembrane protein 54tmp. [source:refseq;acc:nm\_020470]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1128\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
jm1 protein. [source:refseq;acc:nm\_014008]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7353.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7624.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03694\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-gated potassium channel beta-3 subunit (k+ channel beta-3 subunit) (kv-beta-3). [source:swissprot;acc:o43448]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6303.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1129\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
crk-associated substrate (p130cas) (breast cancer anti-estrogen resistance 1 protein). [source:swissprot;acc:p56945]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7946.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8240.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03694\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-gated potassium channel beta-1 subunit (k+ channel beta-1 subunit) (kv-beta-1). [source:swissprot;acc:q14722]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1130\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to putative transmembrane protein; homolog of yeast golgi membrane protein yif1p (yip1p-interacting factor). [source:refseq;acc:nm\_033557]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm3 (mds017). [source:swissprot;acc:q9y4z1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7969.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8263.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0369\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1131\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aflatoxin b1 aldehyde reductase 2 (ec 1.-.-.-) (afb1-ar 2). [source:swissprot;acc:o95154]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 258. [source:refseq;acc:nm\_145310]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7831.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8120.1\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03689\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1132\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
4-hydroxyphenylpyruvate dioxygenase (ec 1.13.11.27) (4hppd) (hpd) (hppdase). [source:swissprot;acc:p32754]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8039.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8336.19\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
alpha/beta hydrolase domain containing protein 3; lung alpha/beta hydrolase 3. [source:refseq;acc:nm\_138340]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1133\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
golgi membrane protein sb140; smooth muscle cell associated protein 5. [source:refseq;acc:nm\_030799]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 261 (dxs6673e protein). [source:swissprot;acc:q14202]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7831.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8120.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03689\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1134\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha/beta hydrolase domain containing protein 1 isoform 2; lung alpha/beta hydrolase protein 1. [source:refseq;acc:nm\_152870]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 262; cell death inhibiting rna. [source:refseq;acc:nm\_005095]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7831.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8120.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03689\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1135\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial precursor (ec 1.2.1.27) (mmsdh). [source:swissprot;acc:q02252]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5790.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6303.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 198 (fused in myeloproliferative disorders protein) (rearranged in atypical myeloproliferative disorder protein). [source:swissprot;acc:q9ubw7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7831.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8120.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03689\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1136\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
10 kda heat shock protein, mitochondrial (hsp10) (10 kda chaperonin) (cpn10). [source:swissprot;acc:q04984]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
actin-like protein 3 (actin-related protein 3) (actin-2). [source:swissprot;acc:p32391]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7831.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8120.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03689\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1137\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
rab acceptor 1 (prenylated); prenylated rab acceptor 1. [source:refseq;acc:nm\_006423]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial precursor (cybs) (succinate-ubiquinone reductase membrane anchor subunit) (qps2) (cii-4) (succinate dehydrogenase complex subunit d) (succinate-ubiquinone oxidoreductase cytochrome b small subunit). [source:swissprot;acc:o14521]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7933.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8226.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03688\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/